SlidesetHIVINTEREST 2016Insights and Lessons Learned on Retention, Adherence, and Achieving and Maintaining Viral Suppression: The Third 90 | Tsitsi ApolloView Slideset
SlidesetHIVINTEREST 2016Knowing Your Data - Update on the Epidemiology of HIV in Children and Adolescents | Landry TsagueView Slideset
SlidesetHIVINTEREST 2016Immediate Offer of HIV Treatment: How To Deliver on the Second 90 (including Supply Chain Management and Drug Stockouts) | Roselyn TobyView Slideset
SlidesetHIVINTEREST 2016Lessons learnt from Ebola Vaccine Trials in Emergency Settings | Godwin Enwere, MD, MScView Slideset
SlidesetHIVINTEREST 2016HIV Testing Strategies: How to Reach 90% Knowledge of Serostatus (including the role of self-testing) | Elizabeth MarumView Slideset
SlidesetHIVINTEREST 2016The Joep Lange Institute / Art and Science in the HIV response | Brandon O’DellView Slideset
SlidesetHIVINTEREST 2016Progress in HIV Prevention and Treatment Scale-Up in Sub-Saharan Africa | Claire MulangaView Slideset
SlidesetHIVINTEREST 2016Ebola to Lassa Fever: Leassons learnt | Ismail Adeshina Abdus-SalamView Slideset
SlidesetHIVINTEREST 2016Lessons learnt About the Ethics of Trial Conduct in Emergency Settings | Morenike Ukpong FolayanView Slideset
SlidesetHIVINTEREST 2016Lessons learnt About Good Participatory Practices in Prevention and Treatment Trials for HIV and for Emerging Pathogens | Lillian MutenguView Slideset
SlidesetHIVINTEREST 2016Lessons learnt from Ebola Therapeutic Trials and Survivor Cohort Studies | Daouda Sissoko, MDView Slideset
